Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Impulse Control Disorders in Parkinson's Disease
NCT01052831Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in impulse control disorder (ICD), sponsored by University of Pennsylvania. Started Nov 2009; status: completed.
02
Drugs
naltrexone
03
Conditions
impulse control disorder (ICD)
Beyond the preview
Go deeper on NCT01052831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052831.